Pictet Asset Management (Switzerland)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $30.3M | Sell |
1,027,977
-220,513
| -18% | -$6.51M | 0.04% | 373 |
|
|
2023
Q1 | $28.8M | Buy |
1,248,490
+77,134
| +7% | +$1.78M | 0.04% | 376 |
|
|
2022
Q4 | $32.6M | Buy |
1,171,356
+168,171
| +17% | +$4.68M | 0.05% | 340 |
|
|
2022
Q3 | $30.8M | Sell |
1,003,185
-11,973
| -1% | -$367K | 0.05% | 348 |
|
|
2022
Q2 | $29.9M | Sell |
1,015,158
-8,405
| -0.8% | -$247K | 0.04% | 375 |
|
|
2022
Q1 | $32.9M | Buy |
1,023,563
+24,943
| +2% | +$802K | 0.04% | 390 |
|
|
2021
Q4 | $44.5M | Buy |
998,620
+130,117
| +15% | +$5.8M | 0.04% | 360 |
|
|
2021
Q3 | $43.8M | Buy |
+868,503
| New | +$43.8M | 0.05% | 359 |
|